European IPO Window Open? Philogen Files $89.6M Offering
By Jennifer Boggs
Thursday, February 10, 2011
If the three initial public offerings to price late last week Pacira Pharmaceuticals Inc., Endocyte Inc. and BG Medicine Inc. are a promising sign for the U.S. IPO market, then perhaps Italian biotech Philogen SpA's plans for a 65.3 million (US$89.6 million) offering on the Milan stock exchange is a signal the European markets are opening up as well.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.